×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Bullish Xspray Pharma Insiders Rewarded As Their Investment Rises To kr11.7m
Simply Wall Street
Insiders who bought Xspray Pharma AB (publ) ( STO:XSPRAY ) stock in the last 12 months were richly rewarded last week...
2 weeks ago
Xspray to present data at ASCO highlighting frequent comedication of PPIs with TKIs in CML-patients and greater than ...
Yahoo Finance
STOCKHOLM, May 23, 2024--Xspray Pharma AB (publ) (Nasdaq Stockholm: XSPRAY), a Swedish pharmaceutical company which uses its innovative...
2 weeks ago
FDA Accepts NDA Resubmission for Dasynoc in CML
OncLive
A new drug application for Dasynoc, a protein kinase inhibitor product candidate for patients with chronic myeloid leukemia,...
3 months ago
FDA Accepts Xspray Pharma's NDA-resubmission for Dasynoc® – PDUFA Date set to 31 July 2024
Business Wire
Xspray Pharma AB (publ) (Nasdaq Stockholm: XSPRAY): The U.S. Food and Drug Administration (FDA) has accepted the resubmission of Xspray...
3 months ago
FDA rejects Xspray's would-be rival to Bristol Myers' Sprycel on dosing, manufacturing concerns
Fierce Pharma
Xspray Pharma received an FDA rejection for its first product Dasynoc. The company is seeking approval in two types of leukemia.
10 months ago
Xspray Pharma Partners with EVERSANA® for the U.S. Launch and Commercialization of its Lead Product, Dasynoc ...
PR Newswire
PRNewswire/ -- Xspray Pharma AB, (NASDAQ Stockholm: XSPRAY) has signed an agreement with EVERSANA® to support the U.S. launch and...
15 months ago
We Think Xspray Pharma (STO:XSPRAY) Needs To Drive Business Growth Carefully
Simply Wall Street
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
3 months ago
Xspray Pharma's XS003 Achieves Superior Bioavailability Milestone, Matching TASIGNA® at Reduced Dosage
Business Wire
Xspray Pharma AB (Stockholm/Nasdaq: XSPRAY) a biotechnology company developing improved PKIs for cancer treatment, through its proprietary...
6 months ago
Pharmacare to expand its facility in Ħal Far
TVMnews.mt
Aqra bil- Malti. Pharmacare, a Maltese pharmaceutical manufacturing company, has signed an agreement with Swedish company Xspray Pharma AB...
27 months ago
Malta's Pharmacare Premium signs facility expansion agreement with Swedish Xspray Pharma
The Malta Independent
Maltese pharmaceutical manufacturing firm Pharmacare Premium Ltd has signed an agreement with Swedish biotechnology company Xspray Pharma AB...
27 months ago